ATE483724T1 - Verfahren zur erhöhung der ausbreitung von b- zellen - Google Patents

Verfahren zur erhöhung der ausbreitung von b- zellen

Info

Publication number
ATE483724T1
ATE483724T1 AT03816201T AT03816201T ATE483724T1 AT E483724 T1 ATE483724 T1 AT E483724T1 AT 03816201 T AT03816201 T AT 03816201T AT 03816201 T AT03816201 T AT 03816201T AT E483724 T1 ATE483724 T1 AT E483724T1
Authority
AT
Austria
Prior art keywords
cells
increase
methods
spread
proliferation
Prior art date
Application number
AT03816201T
Other languages
English (en)
Inventor
Ginette Serrero
Original Assignee
A & G Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & G Pharmaceuticals Inc filed Critical A & G Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE483724T1 publication Critical patent/ATE483724T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT03816201T 2003-02-26 2003-12-17 Verfahren zur erhöhung der ausbreitung von b- zellen ATE483724T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44959303P 2003-02-26 2003-02-26
PCT/US2003/040111 WO2004078782A1 (en) 2003-02-26 2003-12-17 Methods for increasing the proliferation of b cells

Publications (1)

Publication Number Publication Date
ATE483724T1 true ATE483724T1 (de) 2010-10-15

Family

ID=32962489

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03816201T ATE483724T1 (de) 2003-02-26 2003-12-17 Verfahren zur erhöhung der ausbreitung von b- zellen

Country Status (9)

Country Link
US (1) US7651854B2 (de)
EP (1) EP1601687B1 (de)
JP (1) JP4488903B2 (de)
AT (1) ATE483724T1 (de)
AU (1) AU2003297217B2 (de)
CA (1) CA2517140C (de)
DE (1) DE60334499D1 (de)
ES (1) ES2369695T3 (de)
WO (1) WO2004078782A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030215445A1 (en) 1997-05-23 2003-11-20 Ginette Serrero Methods and compositions for inhibiting the growth of hematopoietic malignant cells
US20100111928A1 (en) * 1997-05-23 2010-05-06 A & G Pharmaceutical, Inc. Methods and kits for diagnosis tumorgenicity
US7411045B2 (en) * 2002-11-19 2008-08-12 A&G Pharmaceutical, Inc. Autocrine growth factor receptor antibodies and methods
JP4488903B2 (ja) 2003-02-26 2010-06-23 エイアンドジー ファーマスーティカル インコーポレイテッド Ｂ細胞の増殖を増加させる方法
EP1660010B1 (de) * 2003-08-01 2013-07-24 A & G Pharmaceutical, Inc. Zusammensetzungen und verfahren zur wiederherstellung der empfänglichkeit für eine behandlung mit her2-antagonisten
GB0502046D0 (en) 2005-02-01 2005-03-09 Sinclair Pharmaceuticals Ltd Method
EP2687223B2 (de) * 2006-05-30 2024-11-20 Mayo Foundation For Medical Education And Research Erkennung und Behandlung von Demenz
CA2653974A1 (en) 2006-05-30 2008-02-14 Mayo Foundation For Medical Education And Research Detecting and treating dementia
DE102007033359B4 (de) * 2007-07-16 2010-12-02 Johann Wolfgang Goethe-Universität Frankfurt am Main Verwendung eines Granulins oder einer Granulin-ähnlichen Verbindung zur Therapie oder Prophylaxe von chronischen Schmerzen
US20160075766A1 (en) 2013-05-21 2016-03-17 Roche Diagnostics Operations, Inc. Method for producing antibodies using ovine b-cells and uses thereof
ES2944563T3 (es) * 2014-05-19 2023-06-22 Hoffmann La Roche Procedimiento para producir anticuerpos usando linfocitos B ovinos y usos de los mismos
CN115078233A (zh) * 2022-07-21 2022-09-20 合肥源恩生物技术有限公司 一种利用流式细胞术检测细胞功能的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416192A (en) 1990-04-03 1995-05-16 Bristol-Myers Squibb Company Epithelins: novel cysteine-rich growth modulating proteins
WO1993015195A1 (en) 1992-02-03 1993-08-05 Samuel Solomon Granulins from leukocytes
AU6234194A (en) * 1993-01-15 1994-08-15 Board Of Regents, The University Of Texas System High molecular weight b-cell growth factor: interleukin-14
US6881548B2 (en) 1997-05-23 2005-04-19 A&G Pharmaceutical, Inc. Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy
US20030215445A1 (en) 1997-05-23 2003-11-20 Ginette Serrero Methods and compositions for inhibiting the growth of hematopoietic malignant cells
US7091047B2 (en) 1997-05-23 2006-08-15 A&G Pharmaceutical, Inc. Methods and kits for diagnosing tumorigenicity
US6309826B1 (en) 1997-05-23 2001-10-30 Ginette Serrero 88kDa tumorigenic growth factor and antagonists
US6720159B1 (en) 1997-12-16 2004-04-13 A&G Pharmaceutical, Inc. 88KDA tumorigenic growth factor and antagonists
DK1318837T3 (da) 2000-08-11 2005-01-10 Wyeth Corp Fremgangsmåde til behandling af östrogenreceptorpositivt carcinom
JP2004533206A (ja) 2000-10-11 2004-11-04 アバロン　ファーマシューティカルズ 化学療法のための標的としてのガン関連遺伝子
US7411045B2 (en) 2002-11-19 2008-08-12 A&G Pharmaceutical, Inc. Autocrine growth factor receptor antibodies and methods
JP4488903B2 (ja) 2003-02-26 2010-06-23 エイアンドジー ファーマスーティカル インコーポレイテッド Ｂ細胞の増殖を増加させる方法
US20050175616A1 (en) 2003-05-30 2005-08-11 Peter Kiener PCDGF receptor antibodies and methods of use thereof
US7368428B2 (en) 2003-06-23 2008-05-06 A&G Pharmaceutical, Inc. Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
EP1660010B1 (de) 2003-08-01 2013-07-24 A & G Pharmaceutical, Inc. Zusammensetzungen und verfahren zur wiederherstellung der empfänglichkeit für eine behandlung mit her2-antagonisten
US20080145369A1 (en) 2004-10-13 2008-06-19 Ginette Serrero Autocrine Growth Factor Receptors and Methods

Also Published As

Publication number Publication date
JP4488903B2 (ja) 2010-06-23
EP1601687A4 (de) 2006-07-26
CA2517140A1 (en) 2004-09-16
AU2003297217B2 (en) 2010-01-07
JP2006524484A (ja) 2006-11-02
CA2517140C (en) 2013-12-10
ES2369695T3 (es) 2011-12-05
EP1601687B1 (de) 2010-10-06
DE60334499D1 (de) 2010-11-18
AU2003297217A1 (en) 2004-09-28
EP1601687A1 (de) 2005-12-07
US20070015225A1 (en) 2007-01-18
WO2004078782A1 (en) 2004-09-16
US7651854B2 (en) 2010-01-26

Similar Documents

Publication Publication Date Title
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE602004013492D1 (de) Verfahren und Vorrichtung zur Spamentdeckung
DE60336901D1 (de) Chinazolinon modulatoren von nukleinrezeptoren
DE60308601D1 (de) Verfahren und System zur Authentifizierung von Kommunikationsendgeräten
ATE483724T1 (de) Verfahren zur erhöhung der ausbreitung von b- zellen
DE602004027472D1 (de) Verbessertes verfahren zum wickeln von z-filtermedien
ATE506456T1 (de) Verfahren zur behandlung von lentivirusinfektionen
ATE317595T1 (de) Uberprüfung der beschichtungskante
ATE498676T1 (de) Produkte auf basis von ionischen flüssigkeiten und verfahren zu deren verwendung
ATE366923T1 (de) Vorrichtung zur referenzierung von fluoreszenzsignalen
DE60144248D1 (de) Verfahren zur klonierung von nichtmenschliche säugern unter verwendung von reprogrammiertem donorchromatin oder donorzellen
WO2004021395A3 (en) Method, system, and device for performing quantitative analysis using an ftms
ATE290208T1 (de) Vorrichtung und verfahren zur ausführung elektrischer messungen an gegenständen
DK1604203T3 (da) Fremgangsmåde til direkte bestemmelse af individuelle methotrexatmeta-bolitter
DK1509618T3 (da) Autoimmune sygdomme og NADPH-oxidasedefekter
ATE466283T1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
DE60232827D1 (de) Verfahren zur verbesserung der immunfunktion bei säugern unter verwendung von lactobacillus reuteri-stämmen
ATE489635T1 (de) Vorrichtung, verfahren und verwendung zur behandlung von proben
DE602004024667D1 (de) Verstärkervorrichtung, verfahren und system
ATE347913T1 (de) Verfahren zur identifizierung von wächter- lymphknoten
TR200003695T2 (tr) Anjiyostatin bağlayıcı protein.
ATE346957T1 (de) Verfahren zum nachweis von chloralhydrat in dichloressigsäure
DE60327925D1 (de) Verwendung von löslichem fgl2 als immunosuppressivum
ATE387459T1 (de) Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie
ATE543429T1 (de) Verfahren zur bestimmung des sympathikus-tonus und messsystem dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties